Header Logo

Connection

J. Donahue to Humans

Back to Details
This is a "connection" page, showing publications J. Donahue has written about Humans.
J. Donahue
Connection Strength
0.666
Humans
  1. Mo W, Donahue JK. Gene therapy for atrial fibrillation. J Mol Cell Cardiol. 2024 Nov; 196:84-93.
    View in: PubMed
    Score: 0.036
  2. Tran KV, Donahue JK. Identifying the Role of Lipomatous Metaplasia in Ventricular Tachycardia Mechanism for Nonischemic Cardiomyopathy. JACC Clin Electrophysiol. 2024 06; 10(6):1147-1149.
    View in: PubMed
    Score: 0.035
  3. Donahue JK, Chrispin J, Ajijola OA. Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar. Circ Res. 2024 02 02; 134(3):328-342.
    View in: PubMed
    Score: 0.035
  4. Donahue JK. Editorial commentary: The mundane and the profound of QT prolongation in the opioid abuse crisis. Trends Cardiovasc Med. 2024 Jul; 34(5):286-287.
    View in: PubMed
    Score: 0.033
  5. Benson JM, Wang G, Hutt JA, Wu G, Kaminsky SM, Cram S, Barur R, Donahue JK. Preclinical safety and biodistribution assessment of Ad-KCNH2-G628S administered via atrial painting in New Zealand white rabbits. Basic Clin Pharmacol Toxicol. 2023 Aug; 133(2):179-193.
    View in: PubMed
    Score: 0.033
  6. Callans DJ, Donahue JK. Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia. JACC Clin Electrophysiol. 2022 06; 8(6):713-718.
    View in: PubMed
    Score: 0.031
  7. Kelemen K, Greener ID, Wan X, Parajuli S, Donahue JK. Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar. Nat Commun. 2022 02 11; 13(1):830.
    View in: PubMed
    Score: 0.030
  8. Donahue JK. Editorial commentary: A careful approach to gene editing. Trends Cardiovasc Med. 2021 08; 31(6):349-350.
    View in: PubMed
    Score: 0.027
  9. Donahue JK. Editorial commentary: Epigenetics and cardiovascular disease-From concept to reality. Trends Cardiovasc Med. 2018 07; 28(5):320-321.
    View in: PubMed
    Score: 0.023
  10. Donahue JK. Sequencing of uncertain significance. J Cardiovasc Electrophysiol. 2018 01; 29(1):105-106.
    View in: PubMed
    Score: 0.023
  11. Finet JE, Wan X, Donahue JK. Fusion of Anthopleurin-B to AAV2 increases specificity of cardiac gene transfer. Virology. 2018 01 01; 513:43-51.
    View in: PubMed
    Score: 0.022
  12. Donahue JK. Current state of the art for cardiac arrhythmia gene therapy. Pharmacol Ther. 2017 Aug; 176:60-65.
    View in: PubMed
    Score: 0.022
  13. Liu Z, Hutt JA, Rajeshkumar B, Azuma Y, Duan KL, Donahue JK. Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation. J Thorac Cardiovasc Surg. 2017 11; 154(5):1644-1651.e8.
    View in: PubMed
    Score: 0.022
  14. Donahue JK. Cardiac gene therapy: a call for basic methods development. Lancet. 2016 Mar 19; 387(10024):1137-9.
    View in: PubMed
    Score: 0.020
  15. Donahue JK. Biological Therapies for Atrial Fibrillation: Ready for Prime Time? J Cardiovasc Pharmacol. 2016 Jan; 67(1):19-25.
    View in: PubMed
    Score: 0.020
  16. Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013 Aug 20; 2(4):e000119.
    View in: PubMed
    Score: 0.017
  17. Greener I, Donahue JK. Gene therapy strategies for cardiac electrical dysfunction. J Mol Cell Cardiol. 2011 May; 50(5):759-65.
    View in: PubMed
    Score: 0.014
  18. Amit G, Kikuchi K, Greener ID, Yang L, Novack V, Donahue JK. Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation. 2010 Jun 01; 121(21):2263-70.
    View in: PubMed
    Score: 0.013
  19. Donahue JK. Advice for management of the long-QT patient. J Cardiovasc Electrophysiol. 2010 Aug 01; 21(8):902-4.
    View in: PubMed
    Score: 0.013
  20. Sasano T, Kelemen K, Greener ID, Donahue JK. Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy. Heart Rhythm. 2009 Aug; 6(8 Suppl):S91-7.
    View in: PubMed
    Score: 0.012
  21. Finet JE, Rosenbaum DS, Donahue JK. Information learned from animal models of atrial fibrillation. Cardiol Clin. 2009 Feb; 27(1):45-54, viii.
    View in: PubMed
    Score: 0.012
  22. Donahue JK. Novel strategy to reduce sudden-death risk in the healing phase after myocardial infarction. Circulation. 2009 Jan 06; 119(1):6-8.
    View in: PubMed
    Score: 0.012
  23. Amit G, Qin H, Donahue JK. Biological therapies for atrial fibrillation. J Cardiovasc Pharmacol. 2008 Sep; 52(3):222-7.
    View in: PubMed
    Score: 0.012
  24. Donahue JK, Sasano T, Kelemen K. Gene therapy approaches to ventricular tachyarrhythmias. J Electrocardiol. 2007 Nov-Dec; 40(6 Suppl):S187-91.
    View in: PubMed
    Score: 0.011
  25. Donahue JK. Gene therapy for cardiac arrhythmias: a dream soon to come true? J Cardiovasc Electrophysiol. 2007 May; 18(5):553-9.
    View in: PubMed
    Score: 0.011
  26. Donahue JK. Gender and the heart. Heart Rhythm. 2006 Jul; 3(7):840-1.
    View in: PubMed
    Score: 0.010
  27. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, Calkins H, Donahue JK. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm. 2006 Jul; 3(7):762-8.
    View in: PubMed
    Score: 0.010
  28. Henrikson CA, Brinker JA, Donahue JK. Temporary placement of a defibrillating lead in the treatment of infection and ventricular tachycardia. Heart Rhythm. 2006 Feb; 3(2):222-4.
    View in: PubMed
    Score: 0.010
  29. Donahue JK, Kikuchi K, Sasano T. Gene therapy for cardiac arrhythmias. Trends Cardiovasc Med. 2005 Aug; 15(6):219-24.
    View in: PubMed
    Score: 0.010
  30. Donahue JK, Bauer A, Kikuchi K, Sasano T. Modification of cellular communication by gene transfer. Ann N Y Acad Sci. 2005 Jun; 1047:157-65.
    View in: PubMed
    Score: 0.009
  31. Eldadah ZA, Donahue JK. Successful implantable cardioverter defibrillator placement in an ambulatory patient without thoracic venous access. J Cardiovasc Electrophysiol. 2004 Jun; 15(6):716-8.
    View in: PubMed
    Score: 0.009
  32. Donahue JK. Gene therapy for cardiac arrhythmias. Ann N Y Acad Sci. 2004 May; 1015:332-7.
    View in: PubMed
    Score: 0.009
  33. Donahue JK, Bauer A, Kikuchi K, McDonald AD. Gene transfer techniques for cardiac arrhythmias. Ann Med. 2004; 36 Suppl 1:98-105.
    View in: PubMed
    Score: 0.009
  34. Tomaselli GF, Donahue JK. Somatic gene transfer and cardiac arrhythmias: problems and prospects. J Cardiovasc Electrophysiol. 2003 May; 14(5):547-50.
    View in: PubMed
    Score: 0.008
  35. Nagata K, Marb?n E, Lawrence JH, Donahue JK. Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol. 2001 Mar; 33(3):575-80.
    View in: PubMed
    Score: 0.007
  36. Vaze A, Tran KV, Tanriverdi K, Sardana M, Lessard D, Donahue JK, Barton B, Aurigemma G, Lubitz SA, Lin H, Nasr GH, Mandapati A, Benjamin EJ, Vasan RS, Freedman JE, McManus DD. Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study. PLoS One. 2020; 15(8):e0236960.
    View in: PubMed
    Score: 0.007
  37. Sardana M, Ogunsua AA, Spring M, Shaikh A, Asamoah O, Stokken G, Browning C, Ennis C, Donahue JK, Rosenthal LS, Floyd KC, Aurigemma GP, Parikh NI, McManus DD. Association of Left Atrial Function Index With Late Atrial Fibrillation Recurrence after Catheter Ablation. J Cardiovasc Electrophysiol. 2016 12; 27(12):1411-1419.
    View in: PubMed
    Score: 0.005
  38. Shaikh AY, Esa N, Martin-Doyle W, Kinno M, Nieto I, Floyd KC, Browning C, Ennis C, Donahue JK, Rosenthal LS, McManus DD. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. Crit Pathw Cardiol. 2015 Dec; 14(4):157-65.
    View in: PubMed
    Score: 0.005
  39. McManus DD, Tanriverdi K, Lin H, Esa N, Kinno M, Mandapati D, Tam S, Okike ON, Ellinor PT, Keaney JF, Donahue JK, Benjamin EJ, Freedman JE. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm. 2015 Jan; 12(1):3-10.
    View in: PubMed
    Score: 0.005
  40. Ibrahim MA, Do DV, Sepah YJ, Shah SM, Van Anden E, Hafiz G, Donahue JK, Rivers R, Balkissoon J, Handa JT, Campochiaro PA, Nguyen QD. Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphate. BMC Pharmacol Toxicol. 2013 Jan 14; 14:7.
    View in: PubMed
    Score: 0.004
  41. Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ, Anderson ME. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest. 2011 Aug; 121(8):3277-88.
    View in: PubMed
    Score: 0.004
  42. Lehnart SE, Ackerman MJ, Benson DW, Brugada R, Clancy CE, Donahue JK, George AL, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 2007 Nov 13; 116(20):2325-45.
    View in: PubMed
    Score: 0.003
  43. Reynolds DW, Chen PS, Deal BJ, Donahue JK, Ellenbogen KA, Epstein AE, Friedman PA, Hammill SC, Hohnloser SH, Kanter RJ, Lindsay BD, Natale A, Saffitz J, Stevenson WG. Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. Heart Rhythm. 2005 Sep; 2(9):1025-33.
    View in: PubMed
    Score: 0.002
  44. Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005 Apr; 28(4):336-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.